Moxibustion for Treating Cancer-related fatigue: A Randomized, Placebo-controlled, Pilot Clinical Trial

Korea Institute of Oriental Medicine0 个研究点目标入组 30 人开始时间: 待定最近更新: 2019年3月11日

适应症

试验速览

暂无简介。

•1. Both male and female, 19 years of age and older with a diagnosis of cancer
•2. Had completed cancer-related treatments (e.g. surgery, chemotherapy, radiotherapy, immunotherapy, except for on-going hormone therapy, which must have been initiated at least 3 weeks prior to enrollment) at least 12 weeks
•3. A score = 4 on the Brief Fatigue Inventory (BFI) at least 4 weeks before the randomization
•4. A score = 2 on the Eastern Cooperative Oncology Group (ECOG) performance status

•1. A platelet count less than 50,000/ µL, Hemoglobin less than 9g/d, Hematocrit less than 30%;
•2. Receiving aggressive treatment for anemia (e.g. erythropoietin or blood transfusion);
•3. A score = 11 on HADS (Hospital Anxiety and Depression Scale);
•4. Taking medicine for depression;
•5. A score = 4 on the Numeric rating scale(NRS) for cancer pain
•6. ANC (Absolute neutrophil count) = 1,000;
•7. Had similar fatigue prior to diagnosis of cancer
•8. Had an anticipated survival rate of less than six months
•9. Have a plan of surgery, chemotherapy, radiotherapy during the study
•10. Medication (e.g. stimulant) or Korean medical treatment (e.g. acupuncture, moxibustion, cupping or herbal medicine) for cancer-related fatigue used within the past two weeks
•11. Have a new plan of change of chronic medications or initiation of dietary supplements or non-phamacologic therapy (e.g. exercise, meditation, cognitive behavioral therapy etc.) during the study
•12. Known hypersensitivity reactions or severe adverse events after moxibustion treatment or an inability to cooperate with moxibustion treatment by some reasons, especially difficulty in breathing.
•13.Pregnancy, planning a pregnancy or breast-feeding
•14. In the case that researcher determined participants are inappropriate in clinical trial in the light of clincal symptoms or blood test

发起方